Anong, Johaina S.
HRN: 22-71-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFUROXIME 750MG (VIAL)
09/23/2023
09/29/2023
IVT
190mg
Q8
UTI, Gastritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes